Article

Ziemer Ophthalmics' femtosecond laser receives FDA clearance

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

The system's state-of-the-art laser technology generates shorter, smaller, lower-energy infrared laser pulses that dissect corneal tissue with unprecedented smoothness and precision, according to the company.

Shipment of the system, which designed for a wide range of applications in corneal surgery, is expected in June 2006.

For more information, visit Ziemer Ophthalmics at Booth 1010.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.